Friday 6 November 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue: +5.93%
EPS: +23.1%
Free cash flow: −9.79%
Total debt: −38.9%

Quarter to September 2026, against a year earlier

238.80 1.71 −0.71%

Follow RMD

Alert me

Market cap: $33.7B
P/E: 21.7×
Fwd P/E: 19.6×
Dividend yield: 1.03%
F-score: 6/9
Altman Z: 10.00
Beneish M: −2.59
Dividend safety: 96/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

ResMed Inc. (RMD) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2026: revenue by products and services, and margins
Total Sleep and Breathing Health	4,978	88.05%
Residential Care Software	676	11.95%
Gross margin		61.06%
Operating margin		33.37%
Pre-tax margin		33.95%

Revenue by product or service $m

Line	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Total Sleep and Breathing Health	4,978 88.05%	4,505 87.54%	4,101 87.53%	3,725 88.21%	3,177 88.80%	2,823 88.31%	2,602 88.01%	2,331 89.42%	2,183 93.29%	—	—	—	—	—	—	—	—	—
Residential Care Software	676 11.95%	641 12.46%	584 12.47%	498 11.79%	401 11.20%	374 11.69%	355 11.99%	276 10.58%	157 6.71%	—	—	—	—	—	—	—	—	—
Devices	—	—	—	—	—	—	—	—	—	1,161 56.18%	1,064 57.88%	976 58.13%	847 54.45%	824 54.38%	737 53.82%	699 56.25%	634 58.00%	532 57.79%
Mask Systems Motors And Other Accessories	—	—	—	—	—	—	—	—	—	768 37.15%	746 40.55%	703 41.87%	708 45.55%	691 45.62%	632 46.17%	544 43.75%	459 42.00%	389 42.21%
Other, not broken out	—	—	—	—	—	—	—	—	—	138 6.68%	29 1.57%	—	—	—	—	—	—	—
Revenue	5,653	5,146	4,685	4,223	3,578	3,197	2,957	2,607	2,340	2,067	1,839	1,679	1,555	1,514	1,369	1,243	1,092	921

Operating income by segment $m, and margin

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Total Sleep and Breathing Health	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Residential Care Software	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by segment $m

Line	FY2019	FY2018
Devices And Masks	2,331 89.42%	2,183 93.29%
Software As Service Before Deferred Revenue Adjustment	281 10.79%	157 6.71%
Revenue	2,607	2,340

Operating income by segment $m, and margin

	FY2019	FY2018
Devices And Masks	‡	‡
Corporate and other	‡	‡
Operating income	‡	‡
	‡	‡
	‡	‡
	‡	‡
	‡	‡
	‡	‡
	‡	‡
	‡	‡
	‡	‡
	‡	‡

Revenue by region $m

Line	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2016	FY2015	FY2014	FY2013	FY2012
United States	3,562 63.01%	3,286 63.84%	2,980 63.60%	2,720 64.41%	2,249 62.86%	1,963 61.40%	1,056 57.46%	904 53.86%	—	—	—
Rest of the World	2,091 36.99%	1,861 36.16%	1,705 36.40%	1,503 35.59%	1,329 37.14%	1,234 38.60%	782 42.54%	590 35.16%	349 22.44%	293 19.37%	263 19.23%
Germany	—	—	—	—	—	—	—	184 10.97%	215 13.80%	195 12.88%	181 13.26%
North And Latin America	—	—	—	—	—	—	—	—	839 53.96%	852 56.23%	749 54.73%
France	—	—	—	—	—	—	—	—	152 9.79%	139 9.17%	139 10.18%
Australia	—	—	—	—	—	—	—	—	—	36 2.34%	36 2.61%
Global revenue	—	—	—	—	3,578	3,197	—	—	—	—	—
Revenue	5,653	5,146	4,685	4,223	3,578	3,197	1,839	1,679	1,555	1,514	1,369

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Remaining performance obligations	Q1 FY2027	$386.0M	—	—

	Q1 FY2027
Remaining performance obligations	‡
	‡
	‡
	‡
	‡
	‡
	‡
	‡
	‡
	‡
	‡
	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.

ResMed Inc. (RMD) revenue by segment, product and region

Where the money comes from and where it goes

Revenue by product or service $m

Operating income by segment $m, and margin

Revenue by segment $m

Operating income by segment $m, and margin

Revenue by region $m

Operating figures as reported in each quarter’s results release or filing

Stockrow Weekly